Anika Therapeutics (ANIK) Net Cash Flow (2010 - 2026)
Anika Therapeutics (ANIK) reported Net Cash Flow of -$16.4 million for Q1 2026, down 321.77% year-over-year from $7.4 million in Q1 2025, and down 3600.9% quarter-over-quarter from -$444000.0 in Q4 2025.
Anika Therapeutics (ANIK) Net Cash Flow (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 17 years of Net Cash Flow data on file, last reported at -$16.4 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$16.4 million, down 321.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.3 million (up 19.86% YoY), and the FY2025 annual result was $236000.0, up 101.51% from the prior year.
- Net Cash Flow slipped to -$16.4 million in Q1 2026 per ANIK's latest filing, from -$444000.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $5.6 million in Q3 2023 and troughed at -$16.4 million in Q1 2026.
- A 5-year average of -$3.1 million and a median of -$3.6 million in 2022 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow slumped 1433.3% in 2023, then surged 747.91% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$1.4 million in 2022, then jumped by 254.96% to $2.1 million in 2023, then tumbled by 337.34% to -$5.1 million in 2024, then jumped by 91.26% to -$444000.0 in 2025, then sank by 3600.9% to -$16.4 million in 2026.
- Business Quant data shows ANIK's Net Cash Flow at -$16.4 million in Q1 2026, -$444000.0 in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn | -16.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.43 Mn |
| Mar 31, 2026 | -16.43 Mn |
| Dec 31, 2025 | -444,000.00 |
| Dec 31, 2025 | -444,000.00 |
| Sep 30, 2025 | 5.13 Mn |
| Sep 30, 2025 | 5.13 Mn |
| Jun 30, 2025 | -549,000.00 |
| Jun 30, 2025 | -549,000.00 |
| Mar 31, 2025 | -3.90 Mn |
| Mar 31, 2025 | -3.90 Mn |
| Dec 31, 2024 | -5.08 Mn |
| Dec 31, 2024 | -5.08 Mn |
| Sep 30, 2024 | -791,000.00 |
| Sep 30, 2024 | -791,000.00 |
| Jun 30, 2024 | -5.58 Mn |
| Jun 30, 2024 | -5.58 Mn |
| Mar 31, 2024 | -4.21 Mn |
| Mar 31, 2024 | -4.21 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Dec 31, 2023 | 2.14 Mn |